# Albert Luderer

> Albert A. Luderer is a biotech operator with more than three decades in diagnostics and therapeutics, and the co-founder and CEO of Indi Molecular. He helped spin the company out of Integrated Diagnostics in 2013 alongside Caltech's James Heath and systems biology pioneer Leroy Hood, building it around protein catalyzed capture agents - synthetic peptide molecules engineered to do the work of antibodies. Before Indi, he ran BioTrove through its acquisition by Life Technologies, led Light Sciences, and served as president and COO of bioMerieux. His fingerprints are on widely used diagnostic systems including Vitek II.

- **Role:** Co-Founder & CEO at Indi Molecular
- **Organizations:** Indi Molecular, Integrated Diagnostics, BioTrove, Light Sciences, bioMerieux, Dianon Systems, Boehringer Mannheim, Ciba Corning, Bionano Genomics, PrimeraDx
- **Nationality:** American
- **Education:** Ph.D. (NSF pre-doctoral fellow), Rutgers University, Postgraduate work in immunology, Jefferson Medical College
- **Known for:** Co-invented Vitek II, a global market leader for microbial detection and antibiotic susceptibility testing, Established standard-of-care diagnostics in cancer detection, Participated in creating Siemens Diagnostics through the Ciba Corning joint venture

## Career timeline

- **1980s-1990s** — Senior roles at Corning, Ciba Corning, Boehringer Mannheim and Dianon Systems, commercializing IVD systems including Vitek II
- **1990s-2000s** — President and COO of bioMerieux, Inc.
- **2000s** — CEO of venture-backed therapeutics company Light Sciences
- **2009** — President, CEO and Director of BioTrove; company acquired by Life Technologies
- **2013** — Co-founded Indi Molecular as a spinoff of Integrated Diagnostics with James Heath and Leroy Hood; became CEO
- **2017** — Indi Molecular closes Series A financing (~$11.5M); partners with GE Healthcare on PET tracer candidates

## Achievements

- Co-invented Vitek II, a global market leader for microbial detection and antibiotic susceptibility testing
- Established standard-of-care diagnostics in cancer detection
- Participated in creating Siemens Diagnostics through the Ciba Corning joint venture
- Led BioTrove to acquisition by Life Technologies in 2009
- BioTrove won Frost & Sullivan's North American Drug Discovery Technologies Leadership Award and Inc. 5000 recognition
- Co-founded Indi Molecular and built its protein catalyzed capture agent platform

## Latest updates

- **2017-06** — Indi Molecular raised a Series A round of roughly $11.5M and announced a PET tracer development collaboration with GE Healthcare.

## Links

- Website: https://indimolecular.com
- LinkedIn: http://www.linkedin.com/in/albert-luderer-9139a78

---

Profile page: https://yespress.io/albert-luderer
Published by YesPress — https://yespress.io
Last updated: 2026-08-07